Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Gynecol Oncol. 2015 Jul 3;138(3):614–619. doi: 10.1016/j.ygyno.2015.06.038

Table 2.

Patient demographic and clinicopathologic characteristics stratified by ATR mutation status a

Characteristic ATR Mutation Total p-value b
Absent Present
Ethnicity
 Hispanic 6 1 7 0.423
 Non-Hispanic 351 36 387
 Unknown/Not specified 61 9 70
Race
 African American 25 1 26 0.412
 Caucasian 380 44 424
 Other 9 0 9
 Unknown/Not specified 4 1 5
Stage (FIGO 1988)
 I 280 33 313 0.955
 II 43 4 47
 III 83 8 91
 IV 12 1 13
Tumor grade
 Low grade (grade 1) 158 4 162 0.001
 High grade (grade 2 or 3) 260 42 302
LVSI
 No 283 28 311 0.557
 Yes 126 17 143
 Not reported 9 1 10
Myometrial invasion
 None 57 3 60 0.396
 Inner half 228 28 256
 Outer half 104 11 115
 Serosa 12 3 15
 Not reported 17 1 18
Adjuvant treatment
 No 221 23 244 0.757
 Yes 197 23 220
a

N=464 (11 MSI-high cases without ATR data were excluded)

b

Fisher’s Exact Test